GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gen Ilac Ve Saglik Urunleri Sanayi ve Ticaret AS (IST:GENIL) » Definitions » Debt-to-EBITDA

Gen Ilac Veglik Urunlerinayi ve Ticaret AS (IST:GENIL) Debt-to-EBITDA : 5.03 (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Gen Ilac Veglik Urunlerinayi ve Ticaret AS Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₺1,223 Mil. Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₺64 Mil. Gen Ilac Veglik Urunlerinayi ve Ticaret AS's annualized EBITDA for the quarter that ended in Dec. 2023 was ₺256 Mil. Gen Ilac Veglik Urunlerinayi ve Ticaret AS's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was 5.03.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Debt-to-EBITDA or its related term are showing as below:

IST:GENIL' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.32   Med: 0.69   Max: 1.6
Current: 1.35

During the past 6 years, the highest Debt-to-EBITDA Ratio of Gen Ilac Veglik Urunlerinayi ve Ticaret AS was 1.60. The lowest was 0.32. And the median was 0.69.

IST:GENIL's Debt-to-EBITDA is ranked better than
54.92% of 661 companies
in the Drug Manufacturers industry
Industry Median: 1.61 vs IST:GENIL: 1.35

Gen Ilac Veglik Urunlerinayi ve Ticaret AS Debt-to-EBITDA Historical Data

The historical data trend for Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gen Ilac Veglik Urunlerinayi ve Ticaret AS Debt-to-EBITDA Chart

Gen Ilac Veglik Urunlerinayi ve Ticaret AS Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
Get a 7-Day Free Trial 0.67 0.58 0.32 0.70 1.59

Gen Ilac Veglik Urunlerinayi ve Ticaret AS Quarterly Data
Dec18 Dec19 Mar20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -8.11 1.15 0.51 0.65 5.03

Competitive Comparison of Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Debt-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Debt-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Debt-to-EBITDA falls into.



Gen Ilac Veglik Urunlerinayi ve Ticaret AS Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(1223.324 + 64.364) / 807.823
=1.59

Gen Ilac Veglik Urunlerinayi ve Ticaret AS's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(1223.324 + 64.364) / 255.976
=5.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2023) EBITDA data.


Gen Ilac Veglik Urunlerinayi ve Ticaret AS  (IST:GENIL) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Gen Ilac Veglik Urunlerinayi ve Ticaret AS Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Gen Ilac Veglik Urunlerinayi ve Ticaret AS (IST:GENIL) Business Description

Traded in Other Exchanges
N/A
Address
Mustafa Kemal Mahallesi 2119.Sk. No:3, Cankaya, Ankara, TUR, 06520
Gen Ilac Ve Saglik Urunleri Sanayi ve Ticaret AS is a specialty pharmaceuticals company in Turkey. Its locally manufactured products include Cajex, Contra-K, Epamor, Genkort, Ilopera, among others, while imported products include AvonexPEN, Plegridy, Tecfidera, Regen-D among others.

Gen Ilac Veglik Urunlerinayi ve Ticaret AS (IST:GENIL) Headlines

No Headlines